Skip to main content

Published locations for Node-negative HER2+ BC: End-of-study analysis supports adjuvant treatment with paclitaxel and trastuzumab

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Node-negative HER2+ BC: End-of-study analysis supports adjuvant treatment with paclitaxel and trastuzumab

User login

  • Reset your password
  • /content/node-negative-her2-bc-end-study-analysis-supports-adjuvant-treatment-paclitaxel-and
  • /breast-cancer-icymi/article/261960/breast-cancer/node-negative-her2-bc-end-study-analysis-supports